Skip to main content

EDITORIAL article

Front. Physiol., 07 June 2023
Sec. Membrane Physiology and Membrane Biophysics
This article is part of the Research Topic 30th Anniversary of the Molecular Cloning and Identification of the Na-Cl Cotransporter, NCC View all 7 articles

Editorial: 30th anniversary of the molecular cloning and identification of the Na-Cl cotransporter, NCC

  • 1Unidad UNAM-INC, División de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico
  • 2Department of Physiology and Pharmacology, School of Medicine, Oregon Health and Science University, Portland, OR, United States
  • 3Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
  • 4Molecular Phisiology Unit, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City, Mexico

The present Research Topic includes 6 papers, that aim to review some of the work done characterizing the SLC12A family of cation-coupled electroneutral cotransporters since 1993 in which the NaCl cotransporter (NCC) was first identified, and its cDNA was cloned (Gamba et al., 1994). NCC constitutes the main NaCl entry in the distal convoluted tubule where the fine regulation of its activity by posttranslational modifications, hormones and dietary electrolytes is involved in blood pressure regulation and systemic K+ homeostasis. With 2 original papers and four reviews this Research Topic covers different aspects around research of the SLC12A family, from the original functional properties that are characteristic of NCC to the kinases and phosphatases that regulate its activity, as well as its interactions with other proteins in the kidney, such as ubiquitin ligases and K+ channels.

NCC cloning in 1993 by Gamba and collaborators, opened the door for the future identification of all SLC12A family members, i.e., the Na+-K+-Cl cotransporters, NKCCs and the K+-Cl cotransporters or KCCs. On the following years several contributions reporting the cloning and characterization of the different cotransporters were published (Gamba et al., 1994; Mount et al., 1999). Since then, studies of the SLC12A have extended worldwide and continue providing information of their different roles in the cell and the regulation of several physiological processes. For example, in their present review, Talifu et al. analyze the physiology and pathology of NKCC1 and KCC2 on spinal cord injury, showing how intra and extra neuronal Cl concentration regulation by both cotransporters is involved in central nervous system electrolytes homeostasis. Their report showcases the role of NKCC1 and KCC2 in spinal cord injury, as well as the regulatory mechanisms in the recovery from this disabling disease.

A breakthrough in NCC history occurred when hypertension-causing WNK kinases were linked to NCC function (Wilson et al., 2003). Research in this field established the WNK/SPAK-OSR1 signaling pathway as the main regulatory mechanism for NCC and all the SCL12A members (Vitari et al., 2005). In their present review paper, Uchida et al. reflect on the physiological significance of this regulation particularly on kidney electrolyte homeostasis. They present a dissertation about how the information regarding the WNK modulation of NCC evolved along the years with contributions from many different groups.

Although the phosphorylation process of NCC by the WNK-SPAK pathway has been revealed with certain detail, a less explored area of research is the one related to NCC dephosphorylation by protein phosphatases (PPs). Recent reports have shown that protein phosphatase 1 (PP1), protein phosphatase 2A (PP2A), calcineurin (CN), and protein phosphatase 4 (PP4) are involved in NCC dephosphorylation (Glover et al., 2010; Picard et al., 2014; Shoda et al., 2017). On this Research Topic, Carbajal-Contreras et al. review phosphatase-mediated modulation of NCC and its interactors in some physiological states where NCC activity is fundamental. It is known for instance that the mechanism of the cyclosporine and tacrolimus induce hypertension is in part due to the inhibition of NCC dephosphorylation, promoting its activity and thus the salt reabsorption.

NCC activity has been shown to be affected by many factors, one recently discovered is regulation by extracellular potassium concentration (Hoorn et al., 2020). On the present Research Topic, Rosenbaek et al. analyzed the role of Nedd4-2 on potassium-induced NCC downward expression showing that this E3 ubiquitin ligase is not involved on this process. Nevertheless, lower NCC phosphorylation following high dietary K+ intake is due to reduced activity of the inwardly rectifying potassium channels Kir4.1/Kir5.1, changes in the basolateral plasma membrane potential, and reduced activity of the WNK-SPAK kinase signaling pathway. Meng et al. have shown that Kir5.1 interacts with the E3 ubiquitin ligase Nedd4-2, which then regulates Kir4.1 ubiquitination (Wang et al., 2018b). In their original research paper Meng et al. demonstrate that the effect of high-dietary K+ on Kir4.1/Kir5.1 and ROMK in the distal convoluted tubule (DCT) is not affected by gender or Cl content of the diet.

Finally, NCC structure-function relations, as well as kinetics and pharmacological properties, have been analyzed since its identification 30 years ago, providing fundamental information on NCC structure and function (Monroy et al., 2000). New cryo-EM NCC analysis confirmed and delivered new insights of important transport coordinating residues, ion and thiazide inhibitor binding sites and specific cotransporter regions. The finding of the key residues for polythiazide binding to the transporter is an important discovery that will open the possibility to develop newer and more potent thiazide-type diuretics (Nan et al., 2022). In their review Moreno et al. review the functional characterization of different NCC species from the very first identified NCC to the 2023 cryo-EM NCC structure characterization.

NCC research is far from concluded; new perspectives and information around its regulation, mechanisms, pharmacology, and therapeutics continue to raise questions and provide data about this unique NaCl renal cotransporter. In addition, intense research has also been done with other members of the SLC12 family of solute carriers. The function of these important membrane transporters is implicated in cell volume regulation, in the modulation and type of response to neurotransmitters affecting Cl channels in the postsynaptic membranes and in the transepithelial transport of salt and potassium.

Author contributions

PH formatted, wrote, edited, revised, and approved the final manuscript. DE formatted, edited, revised, and approved the final manuscript. GG formatted, wrote, edited, revised, and approved the final manuscript. All authors contributed to the article and approved the submitted version.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Gamba, G., Miyanoshita, A., Lombardi, M., Lytton, J., Lee, W. S., Hediger, M. A., et al. (1994). Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride cotransporter family expressed in kidney. J. Biol. Chem. 269 (26), 17713–17722. doi:10.1016/s0021-9258(17)32499-7

PubMed Abstract | CrossRef Full Text | Google Scholar

Glover, M., Zuber, A. M., Figg, N., and O’Shaughnessy, K. M. (2010). The activity of the thiazide-sensitive Na(+)-Cl(-) cotransporter is regulated by protein phosphatase PP4. Can. J. Physiol. Pharmacol. 88 (10), 986–995. doi:10.1139/Y10-080

PubMed Abstract | CrossRef Full Text | Google Scholar

Hoorn, E. J., Gritter, M., Cuevas, C. A., and Fenton, R. A. (2020). Regulation of the renal NaCl cotransporter and its role in potassium homeostasis. Physiol. Rev. 100, 321–356. doi:10.1152/physrev.00044.2018

PubMed Abstract | CrossRef Full Text | Google Scholar

Monroy, A., Hebert, S. C., and Gamba, G. (2000). Characterization of the thiazidesensitive Na + -Cl − cotransporter: A new model for ions and diuretics interaction. Am. J. Physiology-Renal Physiol. 279 (1), F161–F169. doi:10.1152/ajprenal.2000.279.1.F161

PubMed Abstract | CrossRef Full Text | Google Scholar

Mount, D. B., Mercado, A., Song, L., Xu, J., George, A. L., Delpire, E., et al. (1999). Cloning and characterization of KCC3 and KCC4, new members of the cation-chloride cotransporter gene family. J. Biol. Chem. 274 (23), 16355–16362. doi:10.1074/jbc.274.23.16355

PubMed Abstract | CrossRef Full Text | Google Scholar

Nan, J., Yuan, Y., Yang, X., Shan, Z., Liu, H., Wei, F., et al. (2022). Cryo-EM structure of the human sodium-chloride cotransporter NCC. Sci. Adv. 8 (45), eadd7176–11. doi:10.1126/sciadv.add7176

PubMed Abstract | CrossRef Full Text | Google Scholar

Picard, N., Trompf, K., Yang, C. L., Miller, R. L., Carrel, M., Loffing-Cueni, D., et al. (2014). Protein phosphatase 1 inhibitor-1 deficiency reduces phosphorylation of renal NaCl cotransporter and causes arterial hypotension. J. Am. Soc. Nephrol. 25 (3), 511–522. doi:10.1681/ASN.2012121202

PubMed Abstract | CrossRef Full Text | Google Scholar

Shoda, W., Nomura, N., Ando, F., Mori, Y., Mori, T., Sohara, E., et al. (2017). Calcineurin inhibitors block sodium-chloride cotransporter dephosphorylation in response to high potassium intake. Kidney Int. 91 (2), 402–411. doi:10.1016/J.KINT.2016.09.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Vitari, A. C., Deak, M., Morrice, N. A., and Alessi, D. R. (2005). The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases. Biochem. J. 391 (1), 17–24. doi:10.1042/BJ20051180

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang, M. X., Su, X. T., Wu, P., Gao, Z. X., Wang, W. H., Staub, O., et al. (2018b). Kir5.1 regulates Nedd4-2-mediated ubiquitination of Kir4.1 in distal nephron. Am. J. Physiol. Ren. Physiol. 315, F986–F996. doi:10.1152/ajprenal.00059.2018

PubMed Abstract | CrossRef Full Text | Google Scholar

Wilson, F. H., Kahle, K. T., Sabath, E., Lalioti, M. D., Rapson, A. K., Hoover, R. S., et al. (2003). Molecular pathogenesis of inherited hypertension with hyperkalemia: The Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc. Natl. Acad. Sci. U. S. A. 100 (2), 680–684. doi:10.1073/pnas.242735399

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: NCC, hypertension, SLC12A, WNK kinases, kidney, structure-function, ubiquitin ligase (E3), phosphatases

Citation: de los Heros P, Ellison DH and Gamba G (2023) Editorial: 30th anniversary of the molecular cloning and identification of the Na-Cl cotransporter, NCC. Front. Physiol. 14:1221806. doi: 10.3389/fphys.2023.1221806

Received: 12 May 2023; Accepted: 02 June 2023;
Published: 07 June 2023.

Edited and reviewed by:

Christoph Fahlke, Helmholtz Association of German Research Centres (HZ), Germany

Copyright © 2023 de los Heros, Ellison and Gamba. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Gerardo Gamba, gamba@biomedicas.unam.mx

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.